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Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, adult-onset motor neuron disease that arises as a
dominantly inherited trait in ∼10% of ALS cases. Mutations in one gene, cytosolic Cu/Zn superoxide dismutase
(SOD1), account for ∼25% of familial ALS (FALS) cases. We have performed a genetic linkage screen in 16 pedigrees
with FALS with no evidence for mutations in the SOD1 gene and have identified novel ALS loci on chromosomes
16 and 20. The analysis of these genes will delineate pathways implicated as determinants of motor-neuron viability
and provide insights into possible therapies for ALS.
Much effort has been directed toward identification of
gene defects that underlie the 10% of ALS cases that are
inherited as dominant traits. To date, only one ALS gene
has been identified (Rosen et al. 1993). It is striking that
forced expression in mice (Gurney et al. 1994; Ripps et
al. 1995; Wong et al. 1995) and rats (Nagai et al. 2001;
Howland et al. 2002) of ALS-associated mutant forms
of this gene, “SOD1” (MIM 147450), produces a rodent
motor-neuron disorder that recapitulates most features
of ALS. Two additional motor neuron–disease genes
have been described recently, although their mutations
are not associated with the phenotype of typical ALS
(Hadano et al. 2001; Yang et al. 2001 [MIM 205100];
Puls et al. 2003 [MIM 607376]). Additional ALS loci
have been identified on chromosomes 18 (Hand et al.
2002 [MIM 606640]) and X (Siddique et al. 1998),
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and pedigrees with ALS–frontotemporal dementia
(MIM 105550) have been genetically linked to chro-
mosome 9 (Hosler et al. 2000).
In this study, we analyzed genetic linkage in 16 fami-
lies in our Boston data set with multigenerational, au-
tosomal dominant transmission of ALS and no muta-
tions in the SOD1 gene. The families range in size from
11 to 67 individuals (table 1). All patients with ALS met
El Escorial criteria for diagnosis (Brooks 1994). In-
formed consent and internal review board approval were
received for this study. Genotype data were generated,
by use of genomic DNA, for 43 patients with familial
ALS (FALS) and 265 relatives, which allowed recon-
struction of genotypes in 450 individuals. Fifty-one
spouses provided allele frequency control subjects. Fam-
ilies were genotyped with 423 simple sequence-repeat
polymorphisms, with an average spacing of 8 cM (max-
imum 14 cM). Fifty-five additional markers defined
regions around neurological disease loci and refined
linked haplotypes. Families not displaying male-to-male
transmission of ALS were screened with 12 markers on
chromosome X. Markers were selected from the Weber
set (8, 8A, 10; Center for Medical Genetics) or the Ge-
nome Database. Mapping information was from Na-
tional Center for Biotechnology Information (NCBI) and
Whitehead Institute databases.
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Table 1
Composition of Family with FALS
Family
Total
Affected
Individuals
Collected
Affected
Individuals
Total
Collected
Individuals
SIMLINK Max
( )vp 0
Mean Age
at Onset
(years)
Mean Disease
Duration
(years)
Male-to-Male
Transmission
4 5 3 16 1.54 59.7  2.3 3.8  2.0 Y
13 4 2 18 1.50 54.5  11.1 4.3  2.5 N
20 10 4 19 2.56 54.3  9.9 5.3  3.4 Y
35 3 1 21 1.38 50.7  2.3 4.7  1.5 N
55 13 5 32 4.06 38.6  13.6 2.0  0.6 Y
64 4 1 8 .66 55.0  8.1 2.9  1.3 Y
81 2 1 9 1.20 45.6  16.3 7.5  7.8 N
86 6 3 7 .82 43.8  5.0 3.0  .8 Y
101 2 1 10 .43 36.0  1.4 5.5  3.5 N
124 4 2 17 1.42 71.0  9.4 1.9  .6 N
159 9 5 25 2.26 45.7  6.3 3.0  1.9 Y
164 3 3 10 .73 69.3  4.0 3.2  2.5 N
166 6 4 26 2.04 62.7  7.4 2.3  .9 Y
171 4 4 11 1.01 48.8  5.0 1.9  .6 N
388 4 2 25 1.88 56.5  1.6 2.9  1.6 N
391 9 2 23 .80 57.0  6.1 15.0  4.2 Y
Total 88 43 277 24.29 53.1  9.6 4.2  3.2
Table 2
Marker Order and Two-Point LOD Scores in Family 55 in
Chromosome 16 Haplotype
Marker
Location on
Chromosome 16
(cM) Peak LOD
Distance of Peak LOD
from Marker
(cM)
D16S764 30 .58 13.8
D16S403 44 2.28 3.0
D16S769 51 1.35 10.7
D16S411 60 2.87 2.1
D16S3253 72 .80 11.9
D16S3053 74 .18 19.8
D16S2620 81 2.03 .1
Forward primers contained a 19-bp 5′ extension of
M13F sequence, which allowed incorporation of dye
during PCR amplification. Products were separated on
6% acrylamide gels by use of LiCor 4200 (LiCor) au-
tomated sequencers, and images were analyzed with
RFLPscan (Scanalytics). Genotype data were used to
calculate two-point and multipoint logarithm-of-odds
(LOD) scores by use of FASTLINK routines MLINK,
ILINK, and LINKMAP (NCBI, version 4.1P) (Lathrop
et al. 1984, 1986). These calculations assume 90% pen-
etrance by age 70 years. Haplotypes were displayed in
Cyrillic (Cherwell Scientific), arranged by hand, and
compared with SIMWALK2 output (Sobel and Lange
1996).
SIMLINK analysis (Ploughman and Boehnke 1989)
demonstrated that these 16 pedigrees should be appro-
priately powered to identify one or more ALS loci (table
1). Thus, for a marker directly on the locus ( cM),vp 0
the total maximal LOD score was 24.28.
Initial analysis of genotype data from 423 markers in
the 16 families identified several regions with two-point
LOD scores 11.5. Of particular interest were regions in
which contiguous markers produced positive scores
within the same family. Two such regions were evident
in a pattern that suggested genetic linkage to FALS. The
first, identified in pedigree 55, spans 51.2 cM (37.8 Mb)
from chromosome 16p12.1 to 16q21. A peak two-point
LOD score of 2.65 at marker D16S753 was observed.
We ran 14 additional markers in this region in all fami-
lies, at an average density of 2 cM. These confirmed the
LOD scores and defined a haplotype that comigrates
with the disease in all affected members of pedigree 55
(table 2; fig. 1A). Analysis of these markers and the
haplotype indicated that the putative ALS locus is
flanked by crossovers at D16S764 and D16S3053 (fig.
1A). A multipoint LOD score was calculated for this
family, with a peak value of 3.29 at D16S403 (table 3;
fig. 1B). Further analysis revealed that the markers that
define the minimum candidate region in family 55 also
define haplotypes in six other pedigrees that segregate
consistently with ALS; lower LOD scores and additional
possible linked regions across the genome preclude the
assignment of this locus as ALS-associated in these
families.
After identifying this linkage to chromosome 16 with
these data, we subsequently investigated unlinked fami-
lies from an independent FALS data set (Northwestern
University [NWU]) for linkage to chromosome 16. We
identified a single family (NWU 9968) that generated a
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Table 3
Multipoint LOD Scores in Family 55 on
Chromosome 16
LOCUS (cM) [MARKER]
MULTIPOINT LOD FOR
Family 55 All Families
34.0 3.12 10.34
44.0 [D16S403] 3.29 59.44
52.3 3.09 25.74
57.9 [D16S753] 2.53 43.25
64.9 2.90 20.66
69.6 [D16S415] 2.96 42.24
79.0 2.89 6.42
Table 4
Marker Order and Two-Point LOD Scores in Family 388 in
Chromosome 20
Marker
Location on
Chromosome 20
(cM) Peak LOD
Distance of Peak LOD
from Marker
(cM)
D20S103 2 3.39 .1
D20S117 3 3.17 .1
D20S199 6 1.70 4.6
D20S473 10 1.22 11.8
D20S889 11 .64 19.6
D20S95 17 1.12 12.2
peak multipoint LOD score of 1.47 at D16S3396 (64
cM). This family had a mean age at onset of 67 years
and a mean disease duration of 2.1 years. There were
eight affected family members, five of whom were sam-
pled. DNA was available on 24 family members. The
maximal expected LOD score for NWU 9968 was 2.25.
In the Boston family set, a second potential ALS-linked
region was identified in family 388. In this pedigree, two
affected individuals of 15 siblings share a unique 5-Mb
segment at chromosome 20ptel (fig. 2A and 2B). Two
contiguous markers (D20S103 and D20S117) produce
two-point LOD scores 13.0, whereas two additional
contiguous markers yield scores 11.5. These were the
highest LOD scores produced in this family in the entire
genome scan of 423 markers. Haplotype analysis re-
vealed a pattern of alleles that is coinherited with the
disease in this family. A sibling who was unaffected at
age 70 years shared alleles below D20S199 with the two
affected individuals, thus potentially implicating the re-
gion above this marker as ALS-associated. Given these
initial positive scores, we analyzed nine additional mark-
ers in this region in all families, at an average marker
density of 1.5 cM. The additional markers further elu-
cidate the haplotype associated with the disease in the
two affected individuals (table 4; fig. 2A). The ALS-
associated haplotype spans the region from the telomere
of the p short arm to D20S199, a distance of ∼6.25 cM
(1 Mb). No other families are genetically linked to this
locus by LOD scores or a shared haplotype. A multipoint
LOD score was calculated for this family, with a peak
value of 3.46 at D20S103 (table 5; fig. 2B).
From a genome scan of 16 familial pedigrees with ALS
without evidence of SOD1 gene mutations, we have
identified two novel ALS gene loci on chromosomes 16
and 20. In our pedigree 55, the linkage to chromosome
16 seems valid for three reasons. First, the markers pro-
ducing the highest LOD scores in this genomewide scan
of 423 polymorphic markers were all located within the
linked region; no similar evidence of linkage was dem-
onstrated for markers at other loci. Second, the linked
markers define a clear haplotype, delineating a minimal
region spanning 51.2 cM (37.8 Mb) of chromosome 16
that is coinherited with the disease in all affected indi-
viduals. Third, we are now aware that two other inves-
tigators each have identified two families linked to this
region (C. Shaw and J. de Belleroche, personal com-
munication). In our pedigree 388, the linkage to chro-
mosome 20 seems probable though somewhat less se-
cure. It is true that, for this family, the best LOD scores
were produced by the markers on the distal short arm
of chromosome 20; no analogous scores were seen
among the 415 other markers tested across the genome.
However, we do not have evidence of similar linkage in
any other family. Moreover, the linkage rests on geno-
types of only two affected individuals, both in the same
generation. Efforts are under way to collect additional
members of this pedigree.
Our understanding of the pathogenesis of ALS will be
enhanced by knowledge of the molecular biological
properties of new ALS genes. In the 10 years since its
identification as the first ALS gene, studies of SOD1 have
provided valuable insights into aspects of the biology of
cell death in ALS, although numerous fundamental
points of controversy remain in understanding the neu-
rotoxicity of mutant SOD1 protein.
For this reason, the identity of the putative ALS genes
on chromosomes 16 and 20 will be of considerable in-
terest. The haplotype we have defined for chromosome
16 spans 51 cM (38 Mb). At present, the number of
genes in this region ranges between 322 and 380, ac-
cording to Ensembl database and NCBI genome brows-
ers. The haplotype on chromosome 20 spans 6 cM (1
Mb), a region that encompasses 20–24 genes, as defined
by the Ensembl and NCBI databases. That we identified
ALS loci in only 2 of 16 families with ALS indicates that
there is heterogeneity in the genetic causes of ALS. It
seems likely that many genes will be implicated in the
pathogenesis of this disease.
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Table 5
Multipoint LOD Scores in Family 388 on
Chromosome 20
LOCUS (cM) [MARKER]
MULTIPOINT LOD FOR
Family 388 All Families
2.1 [D20S103] 3.46 21.33
2.5 3.46 13.41
2.8 [D20S117] 3.46 9.12
4.8 2.95 39.51
6.2 [D20S199] 1.87 29.51
16.2 1.86 40.39
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